Protagonist Therapeutics Inc. (PTGX) Dropped -16.67% or -1.4 To Price $7.0 On Thursday


Protagonist Therapeutics Inc. (PTGX) dropped -16.67% or -1.4 to $7.0. It is close to 62500 shares traded, which is 40.43% compare to the average total volume 154587. The market cap of PTGX is $148.29 million. The year to date change is -60.28%. The 52 week price range is from $7.0 to $23.97. Price of PTGX have changed -0.47% during last week. It have changed -4.55% over last month, -52.22% over last 3 months, -50.68% over last 6 months and -10.64% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PTGX is 13.06. It is 86.57% above current price. The 200-day Moving Averages for PTGX is 15.95. It is 127.86% above current price. The 52-week High is 23.97. It is 242.43% from the current price. The 52-week Low is 7.0. The stock hits 52-week low today.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of PTGX is 0.44 on 2018-04-13. Short % to float is 0.92%. There are some statistics of PTGX. It is has market cap $148.29 million. The share outstanding is 21.18 million. The average volume is 154587. The revenue is 8.78M. The percent of top 15 Institution holding is 59.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PTGX is -33.52%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PTGX is -27.28%.


Tags:

Share this post